157 related articles for article (PubMed ID: 37526849)
1. Regulatory Oversight of Cell, Tissue, and Gene Therapy Products in Singapore.
Ong LL
Adv Exp Med Biol; 2023; 1430():197-210. PubMed ID: 37526849
[TBL] [Abstract][Full Text] [Related]
2. Regulatory Oversight of Cell- and Tissue-Based Therapeutic Products and Gene Therapy Products in Singapore.
Goh CW; Kellathur SN; Ong LL; Wu X
Adv Exp Med Biol; 2015; 871():195-212. PubMed ID: 26374220
[TBL] [Abstract][Full Text] [Related]
3. Regulatory Oversight of Cell and Gene Therapy Products in Malaysia.
Loh EYX; Ab Ghani A; Ahmad R
Adv Exp Med Biol; 2023; 1430():181-195. PubMed ID: 37526848
[TBL] [Abstract][Full Text] [Related]
4. Canadian Regulatory Framework and Regulatory Requirements for Cell and Gene Therapy Products.
Wang J; Griffiths E; Tounekti O; Nemec M; Deneault E; Lavoie JR; Ridgway A
Adv Exp Med Biol; 2023; 1430():91-116. PubMed ID: 37526844
[TBL] [Abstract][Full Text] [Related]
5. Regulatory Oversight of Cell and Gene Therapy Products in Canada.
Ridgway A; Agbanyo F; Wang J; Rosu-Myles M
Adv Exp Med Biol; 2015; 871():49-71. PubMed ID: 26374212
[TBL] [Abstract][Full Text] [Related]
6. Regulation of Cell- and Tissue-Based Therapeutic Products in Singapore.
Kellathur SN
Tissue Eng Part A; 2015 Dec; 21(23-24):2802-5. PubMed ID: 26096855
[TBL] [Abstract][Full Text] [Related]
7. Regulatory Oversight of Gene Therapy and Cell Therapy Products in Korea.
Choi M; Han E; Lee S; Kim T; Shin W
Adv Exp Med Biol; 2015; 871():163-79. PubMed ID: 26374218
[TBL] [Abstract][Full Text] [Related]
8. Overview of the Regulatory Oversight Implemented by the French Regulatory Authorities for the Clinical Investigation of Gene Therapy and Cell Therapy Products.
Lucas-Samuel S; Ferry N; Trouvin JH
Adv Exp Med Biol; 2015; 871():73-85. PubMed ID: 26374213
[TBL] [Abstract][Full Text] [Related]
9. Marketing Regulatory Oversight of Advanced Therapy Medicinal Products in Europe.
Schuessler-Lenz M; Herberts C; Reischl I; Ruiz S; Celis P; Beuneu C; Kjeken R; Timón M
Adv Exp Med Biol; 2023; 1430():1-21. PubMed ID: 37526839
[TBL] [Abstract][Full Text] [Related]
10. A Worldwide Overview of Regulatory Frameworks for Tissue-Based Products.
Oberweis CV; Marchal JA; López-Ruiz E; Gálvez-Martín P
Tissue Eng Part B Rev; 2020 Apr; 26(2):181-196. PubMed ID: 31910099
[TBL] [Abstract][Full Text] [Related]
11. New Japanese Regulatory Frameworks for Clinical Research and Marketing Authorization of Gene Therapy and Cellular Therapy Products.
Nagai S; Ozawa K
Curr Gene Ther; 2017; 17(1):17-28. PubMed ID: 28382858
[TBL] [Abstract][Full Text] [Related]
12. Marketing Regulatory Oversight of Advanced Therapy Medicinal Products (ATMPs) in Europe: The EMA/CAT Perspective.
Salmikangas P; Schuessler-Lenz M; Ruiz S; Celis P; Reischl I; Menezes-Ferreira M; Flory E; Renner M; Ferry N
Adv Exp Med Biol; 2015; 871():103-30. PubMed ID: 26374215
[TBL] [Abstract][Full Text] [Related]
13. United States Food and Drug Administration Regulation of Gene and Cell Therapies.
Bailey AM; Arcidiacono J; Benton KA; Taraporewala Z; Winitsky S
Adv Exp Med Biol; 2015; 871():1-29. PubMed ID: 26374210
[TBL] [Abstract][Full Text] [Related]
14. The Regulation of Cell Therapy and Gene Therapy Products in Switzerland.
Bukovac PK; Hauser M; Lottaz D; Marti A; Schmitt I; Schochat T
Adv Exp Med Biol; 2023; 1430():41-58. PubMed ID: 37526841
[TBL] [Abstract][Full Text] [Related]
15. Current state of Health Canada regulation for cellular and gene therapy products: potential cures on the horizon.
Chisholm J; Ruff C; Viswanathan S
Cytotherapy; 2019 Jul; 21(7):686-698. PubMed ID: 31196821
[TBL] [Abstract][Full Text] [Related]
16. Regulatory Aspects of Cell and Gene Therapy Products: The Japanese Perspective.
Maruyama Y; Noda S; Okudaira S; Sakurai A; Okura N; Honda F
Adv Exp Med Biol; 2023; 1430():155-179. PubMed ID: 37526847
[TBL] [Abstract][Full Text] [Related]
17. Regulatory control of Chinese Proprietary Medicines in Singapore.
Yee SK; Chu SS; Xu YM; Choo PL
Health Policy; 2005 Feb; 71(2):133-49. PubMed ID: 15607377
[TBL] [Abstract][Full Text] [Related]
18. Current practices and reform proposals for the regulation of advanced medicinal products in Canada.
Viswanathan S; Bubela T
Regen Med; 2015; 10(5):647-63. PubMed ID: 26237706
[TBL] [Abstract][Full Text] [Related]
19. Requirements for Clinical Trials with Gene Therapy and Transplant Products in Switzerland.
Marti A
Adv Exp Med Biol; 2015; 871():131-45. PubMed ID: 26374216
[TBL] [Abstract][Full Text] [Related]
20. Advanced Therapy Products in Brazil: Regulatory Aspects.
Junior JBS; Parca RM; Carvalho AB
Adv Exp Med Biol; 2023; 1430():117-133. PubMed ID: 37526845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
